UPMC selects Oracle to power enterprise healthcare analytics initiative

Monday, October 1, 2012 02:49 PM

UPMC, a $10 billion integrated global health enterprise based in Pittsburgh, Penn., has selected Oracle Health Sciences applications and Oracle technology and hardware as a key part of the foundation for its new five-year, $100 million enterprise healthcare analytics initiative.

Oracle solutions will power the enterprise analytics initiative that will bring together data including clinical, genomic, financial, administrative and operational information from more than 200 sources from within UPMC, its health plan and other entities to drive truly personalized care that will yield better patient outcomes.

UPMC looks to achieve better patient outcomes, advance research and continually improve the quality of patient care while reducing costs. Early projects will focus on improving quality reporting and measurement across the health network, extending insight into the effectiveness of specific treatments and cost variations and improving disease prevention through predictive alerts.

To achieve its goals, the nationally acclaimed health system will deploy a wide range of Oracle solutions, including Oracle Health Sciences applications such as Oracle Enterprise Healthcare Analytics, Oracle Health Sciences Network. UPMC will also implement Oracle Fusion Analytics, as well as multiple components of Oracle Fusion Middleware, such as Oracle Hyperion Profitability and Cost Management to support cost-based accounting and Oracle Identity and Access Management Suite Plus to help ensure regulatory compliance and protect sensitive information.

The $100 million project includes a variety of hardware, software, training and other personnel costs. UPMC will build the analytical environment over the next two years to support the health system’s new Center for Innovative Science.

Terms of UPMC’s agreement with Oracle were not disclosed.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs